These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 39126310)

  • 1. Prospects for liquid biopsy approaches in lymphomas.
    Jamal E; Poynton E; Elbogdady M; Shamaa S; Okosun J
    Leuk Lymphoma; 2024 Aug; ():1-11. PubMed ID: 39126310
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unlocking the future of cancer diagnosis - promises and challenges of ctDNA-based liquid biopsies in non-small cell lung cancer.
    Reina C; Šabanović B; Lazzari C; Gregorc V; Heeschen C
    Transl Res; 2024 Oct; 272():41-53. PubMed ID: 38838851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making the Rounds: Exploring the Role of Circulating Tumor DNA (ctDNA) in Non-Small Cell Lung Cancer.
    Shields MD; Chen K; Dutcher G; Patel I; Pellini B
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can a Liquid Biopsy Detect Circulating Tumor DNA With Low-passage Whole-genome Sequencing in Patients With a Sarcoma? A Pilot Evaluation.
    Anderson CJ; Yang H; Parsons J; Ahrens WA; Jagosky MH; Hsu JH; Patt JC; Kneisl JS; Steuerwald NM
    Clin Orthop Relat Res; 2024 Jun; ():. PubMed ID: 38905450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Circulating Tumor DNA Analysis in Lymphomas].
    Suehara Y
    Gan To Kagaku Ryoho; 2021 Oct; 48(10):1209-1213. PubMed ID: 34657049
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
    Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
    Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Tumor DNA in Pediatric Cancer.
    Doculara L; Trahair TN; Bayat N; Lock RB
    Front Mol Biosci; 2022; 9():885597. PubMed ID: 35647029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study.
    Haider Z; Wästerlid T; Spångberg LD; Rabbani L; Jylhä C; Thorvaldsdottir B; Skaftason A; Awier HN; Krstic A; Gellerbring A; Lyander A; Hägglund M; Jeggari A; Rassidakis G; Sonnevi K; Sander B; Rosenquist R; Tham E; Smedby KE
    Front Oncol; 2023; 13():1176698. PubMed ID: 37333831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating Tumor DNA (ctDNA) and Its Role in Gynecologic Malignancies.
    Pomerantz T; Brooks R
    Curr Treat Options Oncol; 2024 Apr; 25(4):510-522. PubMed ID: 38472567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding the Dynamics of Circulating Tumor DNA in Liquid Biopsies.
    Turabi K; Klute K; Radhakrishnan P
    Cancers (Basel); 2024 Jul; 16(13):. PubMed ID: 39001494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Liquid biopsy in hematological malignancies: current and future applications.
    Talotta D; Almasri M; Cosentino C; Gaidano G; Moia R
    Front Oncol; 2023; 13():1164517. PubMed ID: 37152045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
    Mutter JA; Alig SK; Esfahani MS; Lauer EM; Mitschke J; Kurtz DM; Kühn J; Bleul S; Olsen M; Liu CL; Jin MC; Macaulay CW; Neidert N; Volk T; Eisenblaetter M; Rauer S; Heiland DH; Finke J; Duyster J; Wehrle J; Prinz M; Illerhaus G; Reinacher PC; Schorb E; Diehn M; Alizadeh AA; Scherer F
    J Clin Oncol; 2023 Mar; 41(9):1684-1694. PubMed ID: 36542815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Using Liquid Biopsy in the Treatment of Patient with OS.
    Shulman DS; Crompton BD
    Adv Exp Med Biol; 2020; 1257():95-105. PubMed ID: 32483734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell-free circulating tumor DNA supplementing tissue biopsies for identification of targetable mutations: Implications for precision medicine and considerations for reconciling results.
    Hicks JK; Saller J; Wang E; Boyle T; Gray JE
    Lung Cancer; 2017 Sep; 111():135-138. PubMed ID: 28838384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liquid Biopsy by Next-Generation Sequencing: a Multimodality Test for Management of Cancer.
    El Achi H; Khoury JD; Loghavi S
    Curr Hematol Malig Rep; 2019 Oct; 14(5):358-367. PubMed ID: 31346903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating tumour DNA in B-cell lymphomas: current state and future prospects.
    Lakhotia R; Roschewski M
    Br J Haematol; 2021 Jun; 193(5):867-881. PubMed ID: 33550600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes in oncogenic-addicted advanced NSCLC patients with actionable mutations identified by liquid biopsy genomic profiling using a tagged amplicon-based NGS assay.
    Remon J; Swalduz A; Planchard D; Ortiz-Cuaran S; Mezquita L; Lacroix L; Jovelet C; Rouleau E; Leonce C; De Kievit F; Morris C; Jones G; Mercier K; Howarth K; Green E; Pérol M; Saintigny P; Besse B
    PLoS One; 2020; 15(6):e0234302. PubMed ID: 32525942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood has never been thicker: Cell-free DNA fragmentomics in the liquid biopsy toolbox of B-cell lymphomas.
    Meriranta L; Pitkänen E; Leppä S
    Semin Hematol; 2023 Jul; 60(3):132-141. PubMed ID: 37455222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating Tumor DNA to Monitor Therapy for Aggressive B-Cell Lymphomas.
    Kwok M; Wu SP; Mo C; Summers T; Roschewski M
    Curr Treat Options Oncol; 2016 Sep; 17(9):47. PubMed ID: 27461036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumor DNA (ctDNA) in the era of personalized cancer therapy.
    Khatami F; Tavangar SM
    J Diabetes Metab Disord; 2018 Jun; 17(1):19-30. PubMed ID: 30288382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.